TROZX
Price
$26.46
Change
+$0.16 (+0.61%)
Updated
Jun 2 closing price
Net Assets
17.12B
TRWFX
Price
$28.44
Change
+$0.17 (+0.60%)
Updated
Jun 2 closing price
Net Assets
4.32B
Interact to see
Advertisement

TROZX vs TRWFX

Header iconTROZX vs TRWFX Comparison
Open Charts TROZX vs TRWFXBanner chart's image
TROZX vs TRWFX Comparison Chart in %
View a ticker or compare two or three
VS
TROZX vs. TRWFX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TROZX is a StrongBuy and TRWFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TROZX has more cash in the bank: 17.1B vs. TRWFX (4.32B). TRWFX pays higher dividends than TROZX: TRWFX (3.23) vs TROZX (2.95). TROZX was incepted earlier than TRWFX: TROZX (6 years) vs TRWFX (9 years). TRWFX (1.01) is less costly to investors than TROZX (0.65). TROZX is a more actively managed with annual turnover of: 15.00 vs. TRWFX (13.00). TROZX has a lower initial minimum investment than TRWFX: TROZX (0) vs TRWFX (5000). TROZX annual gain was more profitable for investors over the last year : 30.42 vs. TRWFX (20.34). TROZX return over 5 years is better than : 91.32 vs. TRWFX (45.25).
TROZXTRWFXTROZX / TRWFX
Total Expense Ratio0.001.01-
Annual Report Gross Expense Ratio0.651.0164%
Fund Existence6 years9 years-
Gain YTD11.34611.87296%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.1B4.32B396%
Annual Yield % from dividends2.953.2392%
Returns for 1 year30.4220.34150%
Returns for 3 years92.9356.17165%
Returns for 5 years91.3245.25202%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCSA2.920.39
+15.42%
Processa Pharmaceuticals Inc.
ALRS28.920.45
+1.58%
Alerus Financial Corp
STZ136.760.51
+0.37%
Constellation Brands
GBDC13.27-0.09
-0.67%
Golub Capital BDC
SPRB49.40-1.30
-2.56%
Spruce Biosciences Inc